Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Glaucoma, Basic & Translational Research, Imaging & Diagnostics, Health Economics and Policy

Time to Transform the Glaucoma Treatment Paradigm

In April this year, we published the results of our six-year NIHR-funded trial assessing primary treatment for newly-diagnosed glaucoma (1). We compared two interventions; selective laser trabeculoplasty – a well-known, but less widely adopted first-line treatment – and the current standard of care, eye drops. Seven hundred and eighteen patients were randomly allocated to a group and monitored to establish which intervention was more effective in lowering intraocular pressure (IOP). We managed to retain over 90 percent of those patients, which is not only a feat in itself, but a major metric of a successful study. The results were surprising – even to us.

I’ve had conversations with senior colleagues in Australia, America and Europe who are all now using SLT as a first-line treatment on the basis of our study.

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Gus Gazzard

Consultant Ophthalmic Surgeon and Glaucoma Service Director at Moorfields Eye Hospital, London, UK.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register